Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party.

[1]  J. Lafitte,et al.  Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[3]  T. Chevalier,et al.  Re: Stage IIIA category of non-small-cell lung cancer: a new proposal. , 1994, Journal of the National Cancer Institute.

[4]  M Paesmans,et al.  Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  D. Ferrigno,et al.  Prognostic factors in lung cancer: tables and comments. , 1994, The European respiratory journal.

[6]  Mark R. Green,et al.  Effect of radiologic stage III substage on nonsurgical therapy of non‐small cell lung cancer , 1993, Cancer.

[7]  W. Dunn,et al.  Staging systems of lung cancer. , 1993, Mayo Clinic proceedings.

[8]  G. van Kaick,et al.  New aspects in the staging of lung cancer. Prospective validation of the international union against cancer TNM classification , 1992, Cancer.

[9]  W. Curran,et al.  Comparison of the radiation therapy oncology group and american joint committee on cancer staging systems among patients with non‐small cell lung cancer receiving hyperfractionated radiation therapy. A report of the radiation therapy oncology group protocol 83‐11 , 1991, Cancer.

[10]  W. Curran,et al.  Lack of apparent difference in outcome between clinically staged IIIA and IIIB non-small-cell lung cancer treated with radiation therapy. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  R. Tsuchiya,et al.  Prognosis and survival in resected lung carcinoma based on the new international staging system. , 1988, The Journal of thoracic and cardiovascular surgery.

[12]  C. Mountain.  The new International Staging System for Lung Cancer. , 1986, The Surgical clinics of North America.